Hypoxia helps glioma to fight therapy

Current Cancer Drug Targets

Volumn 9, Issue 3, 2009, Pages 381-390

  Amberger Murphy, Verena ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Brain tumour; Chemotherapy; Glioma; Hypoxia; Radiotherapy; Resistance

Indexed keywords

AMITRIPTYLINE; ANGIOPOIETIN RECEPTOR; BEVACIZUMAB; EARLY GROWTH RESPONSE FACTOR 1; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRINOTECAN; NITROPRUSSIDE SODIUM; PROTEIN P53; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN;

AUTOPHAGY; BLOOD BRAIN BARRIER; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STEM CELL; CELL GROWTH; CLINICAL TRIAL; DEPRESSION; ENZYME ACTIVITY; GLIOBLASTOMA; GLIOMA; HUMAN; HYPOXIA; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

ANOXIA; BRAIN NEOPLASMS; CELL HYPOXIA; DRUG RESISTANCE, NEOPLASM; GLIOBLASTOMA; GLIOMA; HUMANS; NITRIC OXIDE; PHAGOCYTOSIS; SUPEROXIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65649115060     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800909788166637     Document Type: Review

References (123)

1. Vaupel, P.; Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004, 14(3), 198-206. (Pubitemid 38903223)
2. Folkman, J.; Hahnfeldt, P.; Hlatky, L. Cancer: looking outside the genome. Nat. Rev. Mol. Cell Biol. 2000, 1(1), 76-79.
3. Vaupel, P.; Thews, O.; Hoeckel, M.; Treatment resistance of solid tumors: role of hypoxia and anemia. Med. Oncol. 2001, 18(4), 243-259. (Pubitemid 34044509)
4. Hockel, M.; Vaupel, P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 2001, 93(4), 266-276. (Pubitemid 32219813)
5. Robe, P. A.; Bentires-Alj, M.; Bonif, M.; Rogister, B.; Deprez, M.; Haddada, H.; Khac, M. T.; Jolois, O.; Erkmen, K.; Merville, M. P.; Black, P. M.; Bours, V. In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin. Cancer Res. 2004, 10(16), 5595-5603. (Pubitemid 39100501)
6. Rong, Y.; Hu, F.; Huang, R.; Mackman, N.; Horowitz, J. M.; Jensen, R. L.; Durden, D. L.; Van Meir, E. G.; Brat, D. J. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res. 2006, 66(14), 7067-7074. (Pubitemid 44197683)
7. Kleihues, P.; Louis, D. N.; Scheithauer, B. W.; Rorke, L. B.; Reifenberger, G.; Burger, P. C.; Cavenee, W. K. The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 2002, 61(3), p. 215-25; discussion 226-229.
8. Gupta, M.; Djalilvand, A.; Brat, D. J. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma. Am. J. Clin. Pathol. 2005, 124(5), 755-768. (Pubitemid 41532511)
9. Brat, D. J.; Kaur, B.; Van Meir, E. G. Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. Front. Biosci. 2003, 8, d100-d116. (Pubitemid 39069966)
10. Kaur, B.; Khwaja, F. W.; Severson, E. A.; Matheny, S. L.; Brat, D. J.; Van Meir, E. G. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005, 7(2), 134-153. (Pubitemid 40590514)
11. Louis, D. N.; Pomeroy, S. L.; Cairncross, J. G. Focus on central nervous system neoplasia. Cancer Cell 2002, 1(2), 125-128. (Pubitemid 41039158)
12. Doran, S.; Thorell, W. In: Brain tumors, population-based epidemiology, environmental risk factors and genetic and hereditary syndromes; Youmans neurological surgery. H. Win, Ed. Saunders, WB: Philadelphia, 2004; pp. 807-815.
13. Stupp, R.; Mason, W. P.; van den Bent, M. J.; Weller, M.; Fisher, B.; Taphoorn, M. J.; Belanger, K.; Brandes, A. A.; Marosi, C.; Bogdahn, U.; Curschmann, J.; Janzer, R. C.; Ludwin, S. K.; Gorlia, T.; Allgeier, A.; Lacombe, D.; Cairncross, J. G.; Eisenhauer, E.; Mirimanoff, R. O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352(10), 987-996. (Pubitemid 40349501)
14. Evans, S. M.; Judy, K. D.; Dunphy, I.; Jenkins, W. T.; Hwang, W. T.; Nelson, P. T.; Lustig, R. A.; Jenkins, K.; Magarelli, D. P.; Hahn, S. M.; Collins, R. A.; Grady, M. S.; Koch, C. J. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin. Cancer Res. 2004, 10(24), 8177-8184. (Pubitemid 40053376)
15. Vaupel, P.; Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007, 26(2), 225-239.
16. Kleihues, P.; Cavenee, W. K.; Eds. Pathology and Genetics of Tumours of the Nervous System; International Agency for Research on Cancer: Lyon, 1997.
17. Brat, D. J.; Castellano-Sanchez, A. A.; Hunter, S. B.; Pecot, M.; Cohen, C.; Hammond, E. H.; Devi, S. N.; Kaur, B.; Van Meir, E. G. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population. Cancer Res. 2004, 64(3), 920-927. (Pubitemid 38176893)
18. Rong, Y.; Durden, D. L.; Van Meir, E. G.; Brat, D. J. 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J. Neuropathol. Exp. Neurol. 2006, 65(6), 529-539. (Pubitemid 44288937)
19. Tehrani, M.; Friedman, T. M.; Olson, J. J.; Brat, D. J. Intravascular Thrombosis in Central Nervous System Malignancies: A Potential Role in Astrocytoma Progression to Glioblastoma. Brain Pathol. 2007, 18(2), 164-171.
20. Guan, M.; Jin, J.; Su, B.; Liu, W. W.; Lu, Y. Tissue factor expression and angiogenesis in human glioma. Clin. Biochem. 2002, 35(4), 321-325.
21. Hamada, K.; Kuratsu, J.; Saitoh, Y.; Takeshima, H.; Nishi, T.; Ushio, Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996, 77(9), 1877-1883. (Pubitemid 26125190)
22. Hamada, K.; Kuratsu, J.; Saitoh, Y.; Takeshima, H.; Nishi, T.; Ushio, Y. Expression of tissue factor in glioma. Noshuyo Byori. 1996, 13(2), 115-118.
23. Moeller, B. J.; Richardson, R. A.; Dewhirst, M. W. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 2007, 26(2), 241-248.
24. Brizel, D. M.; Scully, S. P.; Harrelson, J. M.; Layfield, L. J.; Bean, J. M.; Prosnitz, L. R.; Dewhirst, M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 1996, 56(5), 941-943. (Pubitemid 26065381)
25. Rofstad, E. K. Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 2000, 76(5), 589-605. (Pubitemid 30345160)
26. Subarsky, P.; Hill, R. P. The hypoxic tumour microenvironment and metastatic progression. Clin. Exp. Metastasis 2003, 20(3), 237-250. (Pubitemid 36513228)
27. Rofstad, E. K.; Mathiesen, B.; Henriksen, K.; Kindem, K.; Galappathi, K. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res. 2005, 65(6), 2387-2396. (Pubitemid 40490150)
28. Chan, N.; Koritzinsky, M.; Zhao, H.; Bindra, R.; Glazer, P. M.; Powell, S.; Belmaaza, A.; Wouters, B.; Bristow, R. G. Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res. 2008, 68(2), 605-614.
29. Bindra, R. S.; Glazer, P. M. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett. 2007, 252(1), 93-103. (Pubitemid 46734558)
30. Huang, L. E.; Bindra, R. S.; Glazer, P. M.; Harris, A. L. Hypoxia-induced genetic instability - a calculated mechanism underlying tumor progression. J. Mol. Med. 2007, 85(2), 139-148. (Pubitemid 46188219)
31. Bindra, R. S.; Crosby, M. E.; Glazer, P. M. Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev. 2007, 26(2), 249-260.
32. Gray, L. H.; Conger, A. D.; Ebert, M.; Hornsey, S.; Scott, O. C. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 1953, 26(312), 638-648.
33. Dewhirst, M. W.; Cao, Y.; Li, C. Y.; Moeller, B. Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy. Radiother. Oncol. 2007, 83(3), 249-255. (Pubitemid 46907988)
34. Matsumoto, H.; Takahashi, A.; Ohnishi, T. Nitric oxide radicals choreograph a radioadaptive response. Cancer Res. 2007, 67(18), 8574-8579. (Pubitemid 47437432)
35. Cobbs, C. S.; Whisenhunt, T. R.; Wesemann, D. R.; Harkins, L. E.; Van Meir, E. G.; Samanta, M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003, 63(24), 8670-8673. (Pubitemid 38064042)
36. Cobbs, C. S.; Samanta, M.; Harkins, L. E.; Gillespie, G. Y.; Merrick, B. A.; MacMillan-Crow, L. A. Evidence for peroxynitrite-mediated modifications to p53 in human gliomas: possible functional consequences. Arch. Biochem. Biophys. 2001, 394(2), 167-172. (Pubitemid 32989325)
37. Cobbs, C. S.; Brenman, J. E.; Aldape, K. D.; Bredt, D. S.; Israel, M. A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 1995, 55(4), 727-730.
38. Riobo, N. A.; Clementi, E.; Melani, M.; Boveris, A.; Cadenas, E.; Moncada, S.; Poderoso, J. J. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 2001, 359(Pt 1), 139-145. (Pubitemid 32939215)
39. Gomez-Manzano, C.; Fueyo, J.; Kyritsis, A. P.; Steck, P. A.; Roth, J. A.; McDonnell, T. J.; Steck, K. D.; Levin, V. A.; Yung, W. K. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res. 1996, 56(4), 694-699. (Pubitemid 26055454)
40. Kock, H.; Harris, M. P.;erson, S. C.; Machemer, T.; Hancock, W.; Sutjipto, S.; Wills, K. N.; Gregory, R. J.; Shepard, H. M.; Westphal, M.; Maneval, D. C. Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer 1996, 67(6), 808-815.
41. Lang, F. F.; Yung, W. K.; Sawaya, R.; Tofilon, P. J. Adenovirus-mediated p53 gene therapy for human gliomas. Neurosurgery 1999, 45(5), 1093-1104. (Pubitemid 29517513)
42. Lang, F. F.; Bruner, J. M.; Fuller, G. N.; Aldape, K.; Prados, M. D.; Chang, S.; Berger, M. S.; McDermott, M. W.; Kunwar, S. M.; Junck, L. R.; Chandler, W.; Zwiebel, J. A.; Kaplan, R. S.; Yung, W. K. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. J. Clin. Oncol. 2003, 21(13), 2508-2518. (Pubitemid 46606332)
43. Nashimoto, T.; Komata, T.; Kanzawa, T.; Aoki, H.; Endo, S.; Kon, T.; Uzuka, T.; Takahashi, H.; Kondo, S.; Tanaka, R. Mild hyperthermia plus adenoviral p53 over-expression additively inhibits the viability of human malignant glioma cells. Int. J. Hyperthermia 2005, 21(7), 615-629. (Pubitemid 41684236)
44. Janjetovic, K.; Misirkic, M.; Vucicevic, L.; Harhaji, L.; Trajkovic, V. Synergistic antiglioma action of hyperthermia and nitric oxide. Eur. J. Pharmacol. 2008, 583(1), 1-10.
45. Fiorentini, G.; Giovanis, P.; Rossi, S.; Dentico, P.; Paola, R.; Turrisi, G.; Bernardeschi, P. A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. In Vivo 2006, 20(6A), 721-724. (Pubitemid 46061608)
46. Maier-Hauff, K.; Rothe, R.; Scholz, R.; Gneveckow, U.; Wust, P.; Thiesen, B.; Feussner, A.; von Deimling, A.; Waldoefner, N.; Felix, R.; Jordan, A. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 2007, 81(1), 53-60.
47. Tabatabai, G.; Frank, B.; Mohle, R.; Weller, M.; Wick, W. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. Brain 2006, 129(Pt 9), 2426-2435. (Pubitemid 44522127)
48. Semenza, G. L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 2002. 8(4 Suppl), S62-S67. (Pubitemid 34297081)
49. Brahimi-Horn, M. C.; Chiche, J.; Pouyssegur, J. Hypoxia and cancer. J. Mol. Med. 2007, 85(12), 1301-1307. (Pubitemid 50004093)
50. Moeller, B. J.; Dewhirst, M. W. HIF-1 and tumour radiosensitivity. Br. J. Cancer 2006, 95(1), 1-5. (Pubitemid 43980546)
51. Pouyssegur, J.; Dayan, F.; Mazure, N. M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441(7092), 437-443. (Pubitemid 44050138)
52. Coleman, M. L.; Ratcliffe, P. J.; Oxygen sensing and hypoxia-induced responses. Essays Biochem. 2007, 43, 1-15.
53. Schofield, C. J.; Ratcliffe, P. J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 2005, 338(1), 617-626. (Pubitemid 41541972)
54. Semenza, G. L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007(407), cm8.
55. Zundel, W.; Schindler, C.; Haas-Kogan, D.; Koong, A.; Kaper, F.; Chen, E.; Gottschalk, A. R.; Ryan, H. E.; Johnson, R. S.; Jefferson, A. B.; Stokoe, D.; Giaccia, A. J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 2000, 14(4), 391-396. (Pubitemid 30131884)
56. Zagzag, D.; Zhong, H.; Scalzitti, J. M.; Laughner, E.; Simons, J. W.; Semenza, G. L. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000, 88(11), 2606-2618. (Pubitemid 30331970)
57. Moeller, B. J.; Cao, Y.; Li, C. Y.; Dewhirst, M. W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5(5), 429-441. (Pubitemid 38610245)
58. Wild-Bode, C.; Weller, M.; Rimner, A.; Dichgans, J.; Wick, W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res. 2001, 61(6), 2744-2750. (Pubitemid 32685864)
59. Heissig, B.; Rafii, S.; Akiyama, H.; Ohki, Y.; Sato, Y.; Rafael, T.; Zhu, Z.; Hicklin, D. J.; Okumura, K.; Ogawa, H.; Werb, Z.; Hattori, K. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 2005, 202(6), 739-750. (Pubitemid 41345963)
60. Semenza, G. L. Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discov. Today 2007, 12(19-20), 853-859. (Pubitemid 47554628)
61. Gordan, J. D.; Bertout, J. A.; Hu, C. J.; Diehl, J. A.; Simon, M. C. HIF-2alpha promotes hypoxic cell proliferation by enhancing cmyc transcriptional activity. Cancer Cell 2007, 11(4), 335-347. (Pubitemid 46518312)
62. Bacon, A. L.; Harris, A. L. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann. Med. 2004, 36(7), 530-539. (Pubitemid 39490962)
63. Kaur, B.; Tan, C.; Brat, D. J.; Post, D. E.; Van Meir, E. G. Genetic and hypoxic regulation of angiogenesis in gliomas. J. Neurooncol. 2004, 70(2), 229-243. (Pubitemid 39545734)
64. Plate, K. H.; Breier, G.; Weich, H. A.; Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359(6398), 845-848.
65. Benjamin, L. E.; Golijanin, D.; Itin, A.; Pode, D.; Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 1999, 103(2), 159-165. (Pubitemid 29053133)
66. Benjamin, L. E.; Keshet, E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 1997, 94(16), 8761-8766. (Pubitemid 27335113)
67. Harris, A. L. Hypoxia - a key regulatory factor in tumour growth. Nat. Rev. Cancer 2002, 2(1), 38-47. (Pubitemid 37328806)
68. Maity, A.; Pore, N.; Lee, J.; Solomon, D.; O'Rourke, D. M. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3′-kinase and distinct from that induced by hypoxia. Cancer Res. 2000, 60(20), 5879-5886.
69. Jensen, R. L.; Ragel, B. T.; Whang, K.; Gillespie, D. Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J. Neurooncol. 2006, 78(3), 233-247. (Pubitemid 44018816)
70. Ueda, Y.; Nakagawa, T.; Kubota, T.; Ido, K.; Sato, K. Glioma cells under hypoxic conditions block the brain microvascular endothelial cell death induced by serum starvation. J. Neurochem. 2005, 95(1), 99-110. (Pubitemid 41384429)
71. Ezhilarasan, R.; Mohanam, I.; Govindarajan, K.; Mohanam, S. Glioma cells suppress hypoxia-induced endothelial cell apoptosis and promote the angiogenic process. Int. J. Oncol. 2007, 30(3), 701-707.
72. Brown, R. C.; Mark, K. S.; Egleton, R. D.; Huber, J. D.; Burroughs, A. R.; Davis, T. P. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFkappaB. J. Cell Sci. 2003, 116(Pt 4), 693-700. (Pubitemid 36231308)
73. Reardon, D. A.; Desjardins, A.; Rich, J. N.; Vredenburgh, J. J. The Emerging Role of Anti-Angiogenic Therapy for Malignant Glioma. Curr. Treat. Options Oncol. 2008, 9(1), 1-22.
74. Vredenburgh, J. J.; Desjardins, A.; Herndon, J. E., 2nd.; Dowell, J. M.; Reardon, D. A.; Quinn, J. A.; Rich, J. N.; Sathornsumetee, S.; Gururangan, S.; Wagner, M.; Bigner, D. D.; Friedman, A. H.; Friedman, H. S. Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin. Cancer Res. 2007, 13(4), 1253-1259.
75. Vredenburgh, J. J.; Desjardins, A.; Herndon, J. E., 2nd.; Marcello, J.; Reardon, D. A.; Quinn, J. A.; Rich, J. N.; Sathornsumetee, S.; Gururangan, S.; Sampson, J.; Wagner, M.; Bailey, L.; Bigner, D. D.; Friedman, A. H.; Friedman, H. S.; Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J. Clin. Oncol. 2007, 25(30), 4722-4729.
76. Lee, S. W.; Kim, W. J.; Choi, Y. K.; Song, H. S.; Son, M. J.; Gelman, I. H.; Kim, Y. J.; Kim, K. W. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 2003, 9(7), 900-906. (Pubitemid 36889933)
77. Thurston, G.; Suri, C.; Smith, K.; McClain, J.; Sato, T. N.; Yancopoulos, G. D.; McDonald, D. M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286(5449), 2511-2514. (Pubitemid 30026340)
78. Maisonpierre, P. C.; Suri, C.; Jones, P. F.; Bartunkova, S.; Wiegand, S. J.; Radziejewski, C.; Compton, D.; McClain, J.; Aldrich, T. H.; Papadopoulos, N.; Daly, T. J.; Davis, S.; Sato, T. N.; Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277(5322), 55-60. (Pubitemid 27450643)
79. Stratmann, A.; Risau, W.; Plate, K. H. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 1998, 153(5), 1459-1466. (Pubitemid 28509902)
80. Enholm, B.; Paavonen, K.; Ristimaki, A.; Kumar, V.; Gunji, Y.; Klefstrom, J.; Kivinen, L.; Laiho, M.; Olofsson, B.; Joukov, V.; Eriksson, U.; Alitalo, K. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997, 14(20), 2475-2483. (Pubitemid 27268166)
81. Holash, J.; Maisonpierre, P. C.; Compton, D.; Boland, P.; Alexander, C. R.; Zagzag, D.; Yancopoulos, G. D.; Wiegand, S. J. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999, 284(5422), 1994-1998. (Pubitemid 29309448)
82. Venneri, M. A.; De Palma, M.; Ponzoni, M.; Pucci, F.; Scielzo, C.; Zonari, E.; Mazzieri, R.; Doglioni, C.; Naldini, L. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007, 109(12), 5276-5285. (Pubitemid 46890548)
83. De Palma, M.; Venneri, M. A.; Galli, R.; Sergi Sergi, L.; Politi, L. S.; Sampaolesi, M.; Naldini, L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8(3), 211-226. (Pubitemid 41317592)
84. Lewis, C. E.; De Palma, M.; Naldini, L. Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. Cancer Res. 2007, 67(18), 8429-8432. (Pubitemid 47437413)
85. Du, R.; Lu, K. V.; Petritsch, C.; Liu, P.; Ganss, R.; Passegue, E.; Song, H.; Vandenberg, S.; Johnson, R. S.; Werb, Z.; Bergers, G. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13(3), 206-220.
86. Murdoch, C.; Tazzyman, S.; Webster, S.; Lewis, C. E. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J. Immunol. 2007, 178(11), 7405-7411. (Pubitemid 46847468)
87. Azad, M. B.; Chen, Y.; Henson, E. S.; Cizeau, J.; McMillan-Ward, E.; Israels, S. J.; Gibson, S. B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4(2), 195-204.
88. Maiuri, M. C.; Le Toumelin, G.; Criollo, A.; Rain, J. C.; Gautier, F.; Juin, P.; Tasdemir, E.; Pierron, G.; Troulinaki, K.; Tavernarakis, N.; Hickman, J. A.; Geneste, O.; Kroemer, G. Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 2007, 26(10), 2527-2539. (Pubitemid 46788315)
89. Maiuri, M. C.; Zalckvar, E.; Kimchi, A.; Kroemer, G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 2007, 8(9), 741-752. (Pubitemid 47312826)
90. Komata, T.; Kanzawa, T.; Nashimoto, T.; Aoki, H.; Endo, S.; Nameta, M.; Takahashi, H.; Yamamoto, T.; Kondo, S.; Tanaka, R. Mild heat shock induces autophagic growth arrest, but not apoptosis in U251-MG and U87-MG human malignant glioma cells. J. Neurooncol. 2004, 68(2), 101-111. (Pubitemid 39137334)
91. Brahimi-Horn, M. C.; Pouyssegur, J. Oxygen, a source of life and stress. FEBS Lett. 2007, 581(19), 3582-3591.
92. Helmlinger, G.; Sckell, A.; Dellian, M.; Forbes, N. S.; Jain, R. K. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin. Cancer Res. 2002, 8(4), 1284-1291. (Pubitemid 35177386)
93. Said, H. M.; Staab, A.; Hagemann, C.; Vince, G. H.; Katzer, A.; Flentje, M.; Vordermark, D. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J. Neurooncol. 2007, 81(1), 27-38.
94. Said, H. M.; Hagemann, C.; Staab, A.; Stojic, J.; Kuhnel, S.; Vince, G. H.; Flentje, M.; Roosen, K.; Vordermark, D. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Radiother. Oncol. 2007, 83(3), 398-405. (Pubitemid 46907985)
95. Haapasalo, J. A.; Nordfors, K. M.; Hilvo, M.; Rantala, I. J.; Soini, Y.; Parkkila, A. K.; Pastorekova, S.; Pastorek, J.; Parkkila, S. M.; Haapasalo, H. K. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin. Cancer Res. 2006, 12(2), 473-477. (Pubitemid 43166138)
96. Korkolopoulou, P.; Perdiki, M.; Thymara, I.; Boviatsis, E.; Agrogiannis, G.; Kotsiakis, X.; Angelidakis, D.; Rologis, D.; Diamantopoulou, K.; Thomas-Tsagli, E.; Kaklamanis, L.; Gatter, K.; Patsouris, E. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum. Pathol. 2007, 38(4), 629-638. (Pubitemid 46399896)
97. Svastova, E.; Hulikova, A.; Rafajova, M.; Zat'ovicova, M.; Gibadulinova, A.; Casini, A.; Cecchi, A.; Scozzafava, A.; Supuran, C. T.; Pastorek, J.; Pastorekova, S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004, 577(3), 439-445.
98. Swietach, P.; Vaughan-Jones, R. D.; Harris, A. L.; Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metastasis Rev. 2007, 26(2), 299-310.
99. Hayashi, Y.; Edwards, N. A.; Proescholdt, M. A.; Oldfield, E. H.; Merrill, M. J. Regulation and function of aquaporin-1 in glioma cells. Neoplasia 2007, 9(9), 777-787. (Pubitemid 47523239)
100. McCoy, E.; Sontheimer, H. Expression and function of water channels (aquaporins) in migrating malignant astrocytes. Glia 2007, 55(10), 1034-1043. (Pubitemid 47066743)
101. Badaut, J.; Brunet, J. F.; Grollimund, L.; Hamou, M. F.; Magistretti, P. J.; Villemure, J. G.; Regli, L. Aquaporin 1 and aquaporin 4 expression in human brain after subarachnoid hemorrhage and in peritumoral tissue. Acta Neurochir. Suppl. 2003, 86, 495-498.
102. Fukuda, R.; Zhang, H.; Kim, J. W.; Shimoda, L.; Dang, C. V.; Semenza, G. L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell, 2007, 129(1), 111-122. (Pubitemid 46507584)
103. Brown, J. M.; Giaccia, A. J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 1998, 58(7), 1408-1416. (Pubitemid 28193601)
104. Brown, J. M. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol. Med. Today 2000, 6(4), 157-162. (Pubitemid 30171366)
105. Begley, D. J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 2004, 104(1), 29-45. (Pubitemid 39410561)
106. Zhang, W.; Mojsilovic-Petrovic, J.; Andrade, M. F.; Zhang, H.; Ball, M.; Stanimirovic, D. B. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 2003, 17(14), 2085-2087.
107. Comerford, K. M.; Wallace, T. J.; Karhausen, J.; Louis, N. A.; Montalto, M. C.; Colgan, S. P. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002, 62(12), 3387-3394. (Pubitemid 34651384)
108. Wartenberg, M.; Ling, F. C.; Muschen, M.; Klein, F.; Acker, H.; Gassmann, M.; Petrat, K.; Putz, V.; Hescheler, J.; Sauer, H. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J. 2003, 17(3), 503-505.
109. Ferguson, S. D.; Foster, K.; Yamini, B. Convection-enhanced delivery for treatment of brain tumors. Expert Rev. Anticancer Ther. 2007, 7(12 Suppl), S79-S85.
110. Chung, E. Y.; Shin, S. Y.; Lee, Y. H. Amitriptyline induces early growth response-1 gene expression via ERK and JNK mitogen-activated protein kinase pathways in rat C6 glial cells. Neurosci. Lett. 2007, 422(1), 43-48. (Pubitemid 47077573)
111. Calogero, A.; Lombari, V.; De Gregorio, G.; Porcellini, A.; Ucci, S.; Arcella, A.; Caruso, R.; Gagliardi, F. M.; Gulino, A.; Lanzetta, G.; Frati, L.; Mercola, D.; Ragona, G. Inhibition of cell growth by EGR-1 in human primary cultures from malignant glioma. Cancer Cell Int. 2004, 4(1), 1.
112. Franken, N. A.; Ten Cate, R.; Van Bree, C.; Haveman, J. Induction of the early response protein EGR-1 in human tumour cells after ionizing radiation is correlated with a reduction of repair of lethal lesions and an increase of repair of sublethal lesions. Int. J. Oncol. 2004, 24(4), 1027-1031.
113. Rong, Y.; Post, D. E.; Pieper, R. O.; Durden, D. L.; Van Meir, E. G.; Brat, D. J. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res. 2005, 65(4), 1406-1413. (Pubitemid 40270169)
114. Rak, J.; Yu, J. L.; Luyendyk, J.; Mackman, N. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res. 2006, 66(22), 10643-10646.
115. Pilkington, G. J.; Parker, K.; Murray, S. A. Approaches to mitochondrially mediated cancer therapy. Semin. Cancer Biol. 2007, 18(3), 226-235.
116. Wicha, M.S.; Liu, S.; Dontu, G.; Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 2006, 66(4), 1883-90; discussion 1895-1896.
117. Ignatova, T. N.; Kukekov, V. G.; Laywell, E. D.; Suslov, O. N.; Vrionis, F. D.; Steindler, D. A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39(3), 193-206.
118. Singh, S. K.; Clarke, I. D.; Terasaki, M.; Bonn, V. E.; Hawkins, C.; Squire, J.; Dirks, P. B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63(18), 5821-5828. (Pubitemid 37187480)
119. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells. Nature 2004, 432(7015), 396-401. (Pubitemid 39551674)
120. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004, 64(19), 7011-7021. (Pubitemid 39331011)
121. Yuan, X.; Curtin, J.; Xiong, Y.; Liu, G.; Waschsmann-Hogiu, S.; Farkas, D. L.; Black, K. L.; Yu, J. S. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23(58), 9392-9400. (Pubitemid 40069671)
122. Zhao, D.; Najbauer, J.; Garcia, E.; Metz, M. Z.; Gutova, M.; Glackin, C. A.; Kim, S. U.; Aboody, K. S. Neural stem cell tropism to glioma: Critical role of tumor hypoxia. Mol. Cancer Res. 2008, 6(12), 1819-1829.
123. Rich, J. N. Cancer stem cells in radiation resistance. Cancer Res. 2007, 67(19), 8980-8984. (Pubitemid 47535877)